Latest Articles
The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome - ResearchGate
The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome ResearchGate
Published: Dec. 3, 2024, 6:33 a.m.
Exploring Treatment Options Through Genomic Sequencing in Endometrial Cancer - Cancer Network
Exploring Treatment Options Through Genomic Sequencing in Endometrial Cancer Cancer Network
Published: Dec. 2, 2024, 7:02 p.m.
Thinner endometrial thickness linked to higher placenta accreta spectrum risk - Contemporary Obgyn
Thinner endometrial thickness linked to higher placenta accreta spectrum risk Contemporary Obgyn
Published: Nov. 29, 2024, 4:22 p.m.
Among patients with POI longer duration of endometrial stimulation needed compared with older women using ... - Medical Dialogues
Among patients with POI longer duration of endometrial stimulation needed compared with older women using ... Medical Dialogues
Published: Nov. 29, 2024, 2:45 p.m.
HALP Score Predicts Prognosis in Intermediate-Risk Endometrial Cancer - Physician's Weekly
HALP Score Predicts Prognosis in Intermediate-Risk Endometrial Cancer Physician's Weekly
Published: Nov. 29, 2024, 11:49 a.m.
Endometrial Ablation Devices Market 2024-2033: Size, Growth Estimation, and Industry Insights - openPR
Endometrial Ablation Devices Market 2024-2033: Size, Growth Estimation, and Industry Insights openPR
Published: Nov. 29, 2024, 4:47 a.m.
Meta-analysis of clinicopathologic features of endometrial cancer molecular staging - Frontiers
Meta-analysis of clinicopathologic features of endometrial cancer molecular staging Frontiers
Published: Nov. 28, 2024, 5 p.m.
Conservative Laser Therapy for Vesicovaginal Fistula in Twice-Relapsed Endometrial Cancer: A Case Re - DocWire News
Conservative Laser Therapy for Vesicovaginal Fistula in Twice-Relapsed Endometrial Cancer: A Case Re DocWire News
Published: Nov. 26, 2024, 8:43 p.m.
AstraZeneca Receives Nod To Launch Lynparza For Advanced Endometrial Cancer Treatment In India - NewsX
AstraZeneca Receives Nod To Launch Lynparza For Advanced Endometrial Cancer Treatment In India NewsX
Published: Nov. 26, 2024, 9:58 a.m.
MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p /PI3K/Akt signaling pathway - Frontiers
MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p /PI3K/Akt signaling pathway Frontiers
Published: Nov. 25, 2024, 3:55 p.m.
Link copied to clipboard!